Related Experiment Video
Updated: Jun 30, 2026
03:47
A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
Experience with pulmonary resection for extensively drug-resistant tuberculosis
Yuji Shiraishi1, Naoya Katsuragi, Hidefumi Kita
1Section of Chest Surgery, Fukujuji Hospital, Kiyose, Tokyo, Japan. yujishi@mvb.biglobe.ne.jp
Interactive Cardiovascular and Thoracic Surgery
|September 25, 2008
Summary
Pulmonary resection is a safe and effective treatment for localized extensively drug-resistant tuberculosis (XDR-TB). This surgical approach, combined with chemotherapy, helped patients achieve a sputum-negative status and remain disease-free.
Area of Science:
- Medicine
- Infectious Diseases
- Pulmonology
Background:
- Extensively drug-resistant tuberculosis (XDR-TB) presents a significant global health challenge.
- Optimal management strategies for XDR-TB are still under investigation.
- Pulmonary resection is explored as a treatment option for specific XDR-TB cases.
Purpose of the Study:
- To evaluate the safety and efficacy of pulmonary resection in managing extensively drug-resistant tuberculosis.
- To assess outcomes in patients with localized XDR-TB treated with surgery and chemotherapy.
Main Methods:
- Retrospective review of 54 patients undergoing pulmonary resection for multidrug-resistant tuberculosis (MDR-TB) between 2000 and 2006.
- Identification of patients meeting the WHO definition of XDR-TB.
- Analysis of surgical procedures (pneumonectomy, upper lobectomy) and postoperative outcomes.
Main Results:
- Five patients (9%) met the XDR-TB definition; none were HIV-positive.
- No operative mortality or morbidity was observed.
- All five patients achieved sputum-negative status post-surgery and remained disease-free during follow-up.
Conclusions:
- Pulmonary resection, when combined with state-of-the-art chemotherapy, is a safe and effective treatment for localized XDR-TB.
- Surgical intervention can lead to successful disease eradication in select XDR-TB patients.
- This approach offers a viable management option for drug-resistant tuberculosis.
Related Concept Videos
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:27Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations: